Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV002221173 | SCV002498569 | likely pathogenic | Osteogenesis imperfecta | 2022-04-01 | criteria provided, single submitter | clinical testing | This variant was found in clinical testing. The variant affects a Glycine residue in the lelical domain of collagen I and it is predicted to be pathogenic by all prediction tools available. The variant was found de novo. ACMG criteria: PS2, PM2, PP2, PP3 |